An International Delphi Consensus on the Management of Pollen-Food Allergy Syndrome: A Work Group Report of the AAAAI Adverse Reactions to Foods Committee
The Journal of Allergy and Clinical Immunology: In Practice · 2024-12 · 12 (12) · 3242-3249.e1
DOI: 10.1016/j.jaip.2024.09.037 ↗Kurz gefasst
Delphi-Studie in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2024-12. Verfasst von Taha Al-Shaikhly und 23 weiteren Autor:innen. Beteiligte Einrichtung: Section of Allergy, Asthma & Immunology, Department of Medicine, Penn State College of Medicine, Hershey, Pa. Electronic address: talshaikhly@pennsta…. Hauptthemen laut MEDLINE: Food Hypersensitivity, Rhinitis, Allergic, Seasonal, Delphi Technique. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, National Institutes of Health, National Center for Advancing Translational Sciences.
Abstract (Originalsprache)
BACKGROUND: Pollen-food allergy syndrome (PFAS) is common among patients with allergic rhinitis. Treatment recommendations for patients with PFAS remain variable. OBJECTIVE: To develop consensus recommendation statements for managing patients with PFAS. METHODS: An international panel of allergists, researchers, and nutritionists with an interest in PFAS from 25 different institutions across 11 countries convened and a list of statements was written by 3 authors. The RAND/University of California Los Angeles methodology was adopted to establish consensus on the statements. RESULTS: After 2 Delphi rounds, a consensus was reached on 14 statements. The panel agreed that patients with PFAS would benefit from counseling on the nature and basis of PFAS and the rare chance of more severe systemic reactions and their recognition. The panel agreed on avoiding the raw food responsible for the index reaction, but not potentially cross-reactive fruits/vegetables based on the responsible food of the index reaction. Epinephrine autoinjectors should be recommended for patients with PFAS who experienced severe symptoms (beyond the oropharynx) or for patients considered at risk for severe reactions. The panel agreed that the benefit of allergen immunotherapy remains unclear and that PFAS should not be considered the primary indication for such intervention. CONCLUSIONS: We developed consensus statements regarding counselling patients about the nature and severity of PFAS, potential risk factors, dietary avoidance, epinephrine autoinjector prescription, and allergen immunotherapy consideration for patients with PFAS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section of Allergy, Asthma & Immunology, Department of Medicine, Penn State College of Medicine, Hershey, Pa. Electronic address: talshaikhly@pennstatehealth.psu.edu.
- Department of Pediatrics, Division of Allergy and Immunology, Icahn School of Medicine at Mount Sinai, New York, NY.
- Department of Pediatrics, Hassenfeld Children's Hospital, NYU R. Grossman School of Medicine, New York, NY; Department of Pediatrics, Gastroenterology and Nutrition, Collegium Medicum, University of Warmia and Mazury, O…
- Division of Allergy and Immunology, The Children's Hospital of Philadelphia, Philadelphia, Pa.
- Immunology and Allergy Unit, Department of Medicine, Campbelltown Hospital and Western Sydney University, Sydney, New South Wales, Australia.
- University of Antwerp, Faculty of Medicine and Health Sciences, Department of Immunology, Allergology, Rheumatology and the Infla-Med Centre of Excellence, Antwerp (Belgium) and Immunology, Allergology, Rheumatology, An…
Förderung
- NCATS NIH HHS
- National Institutes of Health
- National Center for Advancing Translational Sciences
Zitieren
APA
Al-Shaikhly, T., Cox, A., Nowak-Wegrzyn, A., Cianferoni, A., Katelaris, C., Ebo, D. G., Konstantinou, G. N., Brucker, H., Yang, H. J., Protudjer, J. L. P., Boechat, J. L., Yu, J. E., Wang, J., Hsu Blatman, K. S., Blazowski, L., Anand, M. P., Ramesh, M., Torres, M. J., Holbreich, M., …, & Skypala, I. (2024). An International Delphi Consensus on the Management of Pollen-Food Allergy Syndrome: A Work Group Report of the AAAAI Adverse Reactions to Foods Committee. The Journal of Allergy and Clinical Immunology: In Practice, 12(12), 3242-3249.e1. https://doi.org/10.1016/j.jaip.2024.09.037
Vancouver
Al-Shaikhly T, Cox A, Nowak-Wegrzyn A, Cianferoni A, Katelaris C, Ebo DG, et al. An International Delphi Consensus on the Management of Pollen-Food Allergy Syndrome: A Work Group Report of the AAAAI Adverse Reactions to Foods Committee. The Journal of Allergy and Clinical Immunology: In Practice. 2024;12(12):3242-3249.e1. doi:10.1016/j.jaip.2024.09.037
BibTeX
@article{AlShaikhly2024,
author = {Al-Shaikhly, Taha and Cox, Amanda and Nowak-Wegrzyn, Anna and Cianferoni, Antonella and Katelaris, Constance and Ebo, Didier G and Konstantinou, George N and Brucker, Hannelore and Yang, Hyeon-Jong and Protudjer, Jennifer L P and Boechat, José Laerte and Yu, Joyce E and Wang, Julie and Hsu Blatman, Karen S and Blazowski, Lukasz and Anand, Mahesh Padukudru and Ramesh, Manish and Torres, Maria J and Holbreich, Mark and Goodman, Richard and Wasserman, Richard L and Hopp, Russell and Sato, Sakura and Skypala, Isabel},
title = {An International Delphi Consensus on the Management of Pollen-Food Allergy Syndrome: A Work Group Report of the AAAAI Adverse Reactions to Foods Committee},
journal = {The Journal of Allergy and Clinical Immunology: In Practice},
year = {2024},
volume = {12},
number = {12},
pages = {3242--3249.e1},
doi = {10.1016/j.jaip.2024.09.037}
}
EUVIMED